Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (401-410 of 548) with videos related to

Pageof 55
Sort By:
Arthritis and Rheumatism|June 8, 2011
Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO studyRachana Hasija, Angela Pistorio, Angelo Ravelli, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
Annals of the Rheumatic Diseases|October 15, 2011
A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosusMarite Rygg, Angela Pistorio, Angelo Ravelli, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Annals of the Rheumatic Diseases|November 3, 2016
EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseasesHelen E Foster, Kirsten Minden, Daniel Clemente, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
European Urology Focus|October 6, 2020
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder CancerMarco Moschini, Luca Afferi, Giorgio Gandaglia, et al.
Nature Reviews. Urology|August 16, 2025
HER2 and urothelial carcinoma: current understanding and future directionsDaniele Raggi, Emanuele Crupi, Filippo Pederzoli, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
The Journal of Rheumatology|July 15, 2023
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III TrialsNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pageof 55

Showing results (401-410 of 548) with videos related to

Sort By:
Pageof 55
Arthritis and Rheumatism|June 8, 2011
Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO studyRachana Hasija, Angela Pistorio, Angelo Ravelli, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
Annals of the Rheumatic Diseases|October 15, 2011
A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosusMarite Rygg, Angela Pistorio, Angelo Ravelli, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Annals of the Rheumatic Diseases|November 3, 2016
EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseasesHelen E Foster, Kirsten Minden, Daniel Clemente, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
European Urology Focus|October 6, 2020
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder CancerMarco Moschini, Luca Afferi, Giorgio Gandaglia, et al.
Nature Reviews. Urology|August 16, 2025
HER2 and urothelial carcinoma: current understanding and future directionsDaniele Raggi, Emanuele Crupi, Filippo Pederzoli, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
The Journal of Rheumatology|July 15, 2023
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III TrialsNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pageof 55